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The evolutionarily conserved GATA-6 transcription factor is an early and persistent marker of heart development in diverse
vertebrate species. We previously found evidence for a functionally conserved heart-specific enhancer upstream of the
chicken GATA-6 (cGATA-6) gene and in the present study we used transgenic mouse assays to further characterize this
regulatory module. We show that this enhancer is activated in committed precursor cells within the cardiac crescent and
that it remains active in essentially all cardiogenic cells through the linear heart stage. Although this enhancer can account
for cGATA-6 gene expression early in the cardiogenic program, it is not able to maintain expression throughout the heart
later in development. In particular, the enhancer is sequentially downregulated along the posterior to anterior axis, with
activity becoming confined to outflow tract myocardium. Enhancers with similar properties have been shown to regulate
the early heart-restricted expression of the mouse Nkx2.5 transcription factor gene. Whereas these Nkx2.5 enhancers are
GATA-dependent, we show that the cGATA-6 enhancer is Nkx-dependent. We speculate that these enhancers are silenced
to allow GATA-6 and Nkx2.5 gene expression to be governed by region-specific enhancers in the multichambered
heart. © 2000 Academic Press
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eINTRODUCTION
The events that lead to the formation of a functional
heart are well conserved among vertebrates (reviewed in
Fishman and Chien, 1997; Lyons, 1996; Mohun and Spar-
row, 1997; Olson and Srivastava, 1996). Briefly, mesodermal
cells that migrate into anterior lateral regions of the embryo
during late gastrulation become committed to a cardiogenic
fate in response to multiple signals from underlying
endodermal cells (Nascone and Mercola, 1995; Schultheiss
et al., 1995). These cells then coalesce over the anterior
intestinal portal and form a crescent of cardiogenic cells
(Rosenquist and De Haan, 1966). The primitive linear heart
emerges as an anterior medial extension of the cardiac
crescent and soon thereafter begins to function as a simple
pump. A series of morphologic events subsequently trans-
forms the primitive heart into a complex multichambered
organ.
1 To whom correspondence should be addressed. Fax: (215) 728-
3574. E-mail: jb_burch@fccc.edu.310xpressed early in the vertebrate cardiogenic lineage,
amely, GATA-4/5/6 (Evans, 1999), Nkx2.5/2.3/2.8 (Evans,
999; Tanaka et al., 1998), MEF2C (Black and Olson, 1998),
/eHAND (Srivastava et al., 1995), and TBX5 (Bruneau et
l., 1999; Horb and Thomsen, 1999). Several lines of evi-
ence indicate that these factors serve critical roles in the
ardiogenic lineage. For example, the expression of domi-
ant negative Nkx and TBX factors in frog embryos inter-
eres with myocardial differentiation in vivo (Fu et al.,
998; Grow and Krieg, 1998; Horb and Thomsen, 1999).
imilarly, an antisense strategy revealed that the GATA-4/
/6 class of factors is required for cultured P19 embryonic
tem cells to differentiate into cardiomyocytes (Grepin et
l., 1997). On the other hand, the forced expression of
kx2.5 in fish and frog embryos (Chen and Fishman, 1996;
leaver et al., 1996) is sufficient to induce ectopic cardiac
ene expression and cardiac hyperplasia. Similar results
ave been obtained in response to ectopic GATA-4/5/6
xpression (Gove et al., 1997; Jiang and Evans, 1996).
Whereas different classes of heart-restricted factors are0012-1606/00 $35.00
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311Nkx-Dependent cGATA-6 Enhancerof a given class of factors are, in general, functionally
redundant in this regard. For example, neither mGATA-4
nor mGATA-6 is essential for myocardial cell differentia-
tion in vivo (Koutsourakis et al., 1999; Molkentin et al.,
1997; Morrisey et al., 1998; Narita et al., 1997). Many of
these factors do, however, play unique roles during heart
morphogenesis. For example, mouse Nkx2.5 (Lyons et al.,
995; Tanaka et al., 1999a) and eHAND (Firulli et al., 1998)
re required for development to proceed beyond the heart-
ooping stage, while mouse dHAND (Srivastava et al., 1997)
nd MEF2C (Lin et al., 1997) are required for right ventricle
ormation. Mutations in the human Nkx2.5 (Schott et al.,
998) and TBX5 (Basson et al., 1999; Li et al., 1997) genes
cause septation and conduction system defects.
These heart-restricted factors typically function synergis-
tically with other heart-restricted and ubiquitous factors to
regulate their target genes. Furthermore, several pairs of
heart-restricted factors have been shown to interact directly
with each other at cardiac gene promoters and enhancers
that contain the respective pairs of binding sites (Durocher
et al., 1997; Lee et al., 1998; Sepulveda et al., 1998).
Interestingly, GATA-4 can physically interact with Nkx2.5
while GATA-6 does not appear to, despite the fact that the
interaction domains for these two GATA factors are very
similar (Charron et al., 1999).
The transcriptional hierarchies that regulate these heart-
restricted transcription factor genes are just beginning to be
elucidated. Transgenic mouse assays have revealed that the
chicken GATA-6 (cGATA-6) gene (He and Burch, 1997) and
the mouse Nkx2.5 (mNkx2.5) gene (Lien et al., 1999; Reecy
et al., 1999; Searcy et al., 1998; Tanaka et al., 1999b) are
regulated by multiple heart-restricted enhancers, and in the
present study we show that the more distal cGATA-6
enhancer is sufficient to account for the early heart-
restricted expression pattern of this gene. Furthermore, and
despite the presence of binding sites for several classes of
(early and persistent) heart-restricted factors, we demon-
strate that this enhancer is sequentially downregulated in
the atria, future left ventricle, and future right ventricle.
This downregulation occurs as development proceeds be-
yond the linear heart stage (i.e., when many endogenous
genes become restricted to chamber-specific patterns of
expression). Finally, we demonstrate that this cGATA-6
enhancer is directly regulated by Nkx2.5.
MATERIALS AND METHODS
Oligonucleotides
The following oligonucleotides were used (as described below):
JB1072, 59 GATCTGCTGAAAATAACCCTAG 39; JB1073, 59
TAGGGTTATTTTTAGCAGATC 39; JB1074, 59 GATCTGT-
AAGTGCCCTAG 39; JB1075, 59 CTAGGGCACTTGACAGATC
9; JB1093, 59 ACCGTAACCACTTCAGTGGTCTTTTC 39;
B1094, 59 GAAAAGACCACTGAAGTGGTTACGGT 39; JB1250,
9 ACCGTAACCAAGATCTTGGTCTTTTC 39; JB1251, 59
AAAAGACCAAGATCTTGGTTACGGT 39; JB1254, 59 TGCT-Copyright © 2000 by Academic Press. All rightGAAGTGCTGCAGCA 39; JB1256, 59 TGCTGCAGCCTCGAGG-
TACCGGG 39; JB1257, 59 CCCGGTACCTCGAGGCTGCAGCA
39; JB1192, 59 TCATCTAGATTCTGCAGCATGTTG 39; and
JB0821, 59 ACGTCTAGAGTCCTCATGATTTGGCTG 39.
Transgenic Constructs
The cG6/lacZ-A and cG6/lacZ-B constructs were described in
detail in a previous publication (He and Burch, 1997), in which they
were denoted p(29.2/10.8)GATA-6/lacZ and p(21.5/10.8)GATA-
/lacZ, respectively. The cG6/lacZ-C construct was also previously
escribed (see line 10 of Fig. 5 in He and Burch, 1997).
Four cG6/lac-Z constructs were made by inserting cGATA-6
ragments upstream of the basal promoter in the hsp68/lacZ vector
Kothary et al., 1989). The cG6/lacZ-D construct was made by
ransferring the (26.6 to 25.3 kb) cGATA-6 fragment from cG6/
acZ-C into the SmaI site of hsp68/lacZ. The (26.6 to 26.0 kb)
egion was PCR amplified from cG6/lacZ-D using the JB0821/1192
ligos and cloned into the SmaI site of hsp68/lacZ to yield the
G6/lacZ-E construct. A PCR-based protocol (Davis and Burch,
996) was used to sequentially mutate the two Nxk2.5 sites in
G6/lacZ-E to yield cG6/lacZ-E-mut. In particular, the JB1250/
251 and JB1256/1257 oligos were used to mutate the Nkx2.5/A
nd Nkx2.5/B sites, respectively. The JB0821/1192 oligos were
hen used to amplify the mutated (26.6 to 26.0 kb) cassette, which
as subsequently inserted into hsp68/lacZ. The cG6/lacZ-F con-
truct was made by cloning the cGATA-6 (26.4 to 26.0 kb) PstI
ragment into the PstI site of hsp68/lacZ. Inserts and cloning
unctions were sequenced. The mutations introduced into cG6/
acZ-E-mut did not create new binding sites, as determined by
creening transcription factor databases (Wisconsin Package Ver-
ion 10.0; Genetics Computer Group, Madison, WI; also Heinem-
yer et al., 1999).
Transgenic mice were prepared and analyzed according to stan-
ard protocols (Hogan et al., 1994). Transgenic embryos and mice
ere identified by PCR analysis (Hogan et al., 1994). Embryos were
staged using the criteria of Kaufman (1995). Representative speci-
mens were dehydrated in a graded series of ethanol, cleared in
isopropanol, embedded in paraffin, and serially sectioned at 5 mm.
After deparaffination in xylene and rehydration, slides were coun-
terstained for 6 min in nuclear fast red (0.1% w/v in 5% aluminum
sulfate).
Gel Shift Assays
COS-7 cells (ATCC) were grown in 10% FCS/DMEM to a
density of 800,000 cells per 10-cm dish and transfected with 10 mg
of a CMV-driven Nkx2.5 expression vector (Chen and Schwartz,
1995) using a protocol recommended for LipofectAMINE (Gibco
BRL). Nuclear extracts were prepared from transfected and control
cells using a published protocol (Schreiber et al., 1989). Each dish
yielded 100 ml of nuclear extract.
Gel shift assays were carried out using 1-ml aliquots of nuclear
extract according to a published protocol (Chen and Schwartz,
1995) except that 2 mg of poly(dI/dC) was used per 30-ml reaction
nd the samples were incubated on ice. Probes and competition
inding sites were made by annealing the following pairs of
ynthetic oligonucleotides (see above) as previously described
Davis and Burch, 1996): Nkx2.5/A (JB1093/1094), Nkx2.5/B
JB1254/1255), Nkx2.5/A-mutant (JB1250/1251), Nkx2.5/B-mutant
JB1256/1257), Nkx2.5 consensus (JB1074/1075), and MEF-2 con-
ensus (JB1072/1073).s of reproduction in any form reserved.
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312 Davis, Wessels, and BurchRESULTS
A Heart-Specific Hypersensitive Site, Located 6.2
kb Upstream of the cGATA-6 Gene, Highlights a
Heart-Specific Enhancer
We previously used transient transgenic (F0) mouse as-
says to screen for control regions that might regulate the
heart-restricted expression of the cGATA-6 gene. Our anal-
ysis of two cGATA-6/lacZ constructs (denoted cG6/lacZ-A
and cG6/lacZ-B; see Fig. 1) in embryonic day 11 (E11)
transgenic mouse embryos provided evidence for two such
functionally conserved control regions (He and Burch,
1997). One control region, which mapped within 1.5 kb of
the gene, directed expression in the atrioventricular canal
FIG. 1. Cartoon of cG6/lacZ transgenic constructs. The cGATA-6
with the noncoding and coding regions represented as white and bla
HS site (marked by a vertical arrow) that highlights a distal hea
cG6/lacZ constructs that were assayed in transgenic mice. The cG
constructs A–C, whereas it was assayed in conjunction with
cG6/lacZ-E-mut construct has mutations over both of the Nkx2.5
cG6/lacZ-B constructs were previously assayed in transient transge
p(29.2/10.8)GATA-6/lacZ and p(21.5/10.8)GATA-6/lacZ, respectCopyright © 2000 by Academic Press. All righthat lies between the primitive atrium and the primitive
entricle. The other control region, which mapped 1.5 to
.2 kb upstream of the gene, was required to direct trans-
ene expression in the primitive ventricle and outflow tract
ot) at E11.
We also reported that a heart-specific hypersensitive (HS)
ite flanks the cGATA-6 gene and we inferred that this HS
ite might highlight the heart-specific control region de-
cribed above (He and Burch, 1997). We subsequently deter-
ined that this HS site is located precisely 6.2 kb upstream
f the cGATA-6 gene (data not shown), near consensus
inding sites for several heart-restricted transcription fac-
ors (see below). We therefore decided to analyze this distal
egion further.
has seven exons, the first two of which are depicted on the top line,
xes, respectively. The cGATA-6 gene is flanked by a heart-specific
ecific enhancer (represented as an oval). Depicted below are the
-6 enhancer was assayed upstream of the cGATA-6 promoter in
hsp68 basal promoter in the other constructs. Note that the
s in the cGATA-6 enhancer. Note also that the cG6/lacZ-A and
ice (He and Burch, 1997). These constructs were previously named
(He and Burch, 1997).gene
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313Nkx-Dependent cGATA-6 EnhancerTo determine whether a control region (in particular, an
autonomous enhancer) is indeed located 6.2 kb upstream of
the cGATA-6 gene, we cloned a 1.4-kb fragment that spans
this distal region into a heterologous (hsp68/lacZ) test
vector and assayed the resultant construct (denoted cG6/
lacZ-D; see Fig. 1) in transgenic mice. Note that the basal
promoter in this test vector (Kothary et al., 1989) is respon-
sive to a broad range of heart-specific (and other) enhancers
in transgenic mice. Also, in contrast to our previous tran-
sient (F0) transgenic assays, we made several lines of
transgenic mice so that the cGATA-6 distal enhancer could
be assayed (in F1 embryos) at different developmental
stages.
All four of the cG6/lacZ-D lines that we examined were
FIG. 2. The cGATA-6 gene is flanked by a distal enhancer that dir
expression patterns for three lines of cG6/lacZ-D transgenic mice (se
transgenic embryos are shown below in D–F. Note that expression
the future left ventricle (lv) and atrium (at). This transgene is also
no staining is evident in endocardial cushions (ec). Modest ectopic
(D).Copyright © 2000 by Academic Press. All rightound to express the transgene in a heart-specific manner at
9.5. Three of these lines displayed robust expression (see
igs. 2A–2C), whereas the fourth line displayed weak ex-
ression (data not shown) and was not analyzed further.
lthough the cG6/lacZ-D transgene was expressed
hroughout the hearts of these E9.5 embryos, in each case
here was a more or less obvious bias in favor of the anterior
egments of the heart. This bias is better revealed in the
ections shown below each of the respective embryos. For
he cG6/lacZ-D3 embryo (Fig. 2F), expression is obviously
igher in the future right ventricle (rv) than the future left
entricle (lv) and common atrial (at) chamber. Whereas a
imilar bias is seen for the cG6/lacZ-D1 embryo (Fig. 2D),
he transition zone (between high and low expression) in
obust heart-specific expression in transgenic mice. (A–C) The lacZ
. 1) assayed at E9.5. Transverse sections through the hearts of these
gher in the outflow tract (ot) and future right ventricle (rv) than in
essed weakly in some (e.g., see F) regions of endocardium (en) but
ression is evident in the neural tube (nt) for one of the three linesects r
e Fig
is hi
expr
exps of reproduction in any form reserved.
this specimen lies within the future rv rather than at the
314 Davis, Wessels, and Burchgroove that demarcates these two chambers. The cG6/
lacZ-D2 embryo (Fig. 2E) also expresses the transgene at
somewhat higher levels in the future right ventricle.
These sections also confirm that the cGATA-6 distal
enhancer directs expression in myocardial cells, within
both the (superficial) compact zone and the (internal) tra-
beculae. The transgene appears to be expressed weakly in
some regions of endocardium (Fig. 2E) but not in endocar-
dial cushions (Figs. 2D and 2F). The cG6/lacZ-D1 embryo
also displays a low level of ectopic expression in the neural
tube (Fig. 2D).
The cGATA-6 Enhancer Is an Early, but Transient,
Marker of the Cardiogenic Lineage
Additional matings were set up to assay cGATA-6 en-
hancer activity at earlier developmental stages. All three
cG6/lacZ-D lines displayed similar patterns of expression
from E7.5 to E9.0. A representative panel of images for the
cG6/lacZ-D1 line is presented in Fig. 3. Note that the
cGATA-6 enhancer is active in the cardiac crescent as early
as E7.5 (Fig. 3A), in concert with the first wave of endoge-
nous heart-restricted genes (GATA-4/5/6, Nkx2.5, MEF2-C,
and TBX5). Transgene expression increased within this
well-delineated crescent between E7.5 and E8.0 (Figs. 3B
and 3C) and remained robust as the linear heart formed and
proceeded to loop to the right (Figs. 3D–3F).
Sections of the embryos in Figs. 3B–3D are shown in Figs.
3G–3I. The images in Figs. 3G and 3H confirm that expres-
sion in the cardiac crescent at E7.5–E8.0 occurs within
cardiogenic mesoderm. Similarly, the image in Fig. 3I
confirms the impression (from Fig. 3D) that the transgene is
expressed rather uniformly in atrial, ventricular, and out-
flow tract myocardium in the primitive heart at E8.25.
Based on a comparison of the images shown in Figs. 2 and 3,
we conclude that a bias in transgene expression becomes
manifest along the posterior to anterior axis of the heart
between E8.25 and E9.5. Note that the image in Fig. 3I also
provides evidence for weak expression in regions of endo-
cardium, in accord with the results presented above (in Fig.
2F).
We also assayed all three lines of cG6/lacZ-D trans-
genic mice at later developmental stages. As shown in
Fig. 4, the bias in favor of more anterior (arterial) regions
of the heart, which was evident as early as E9.5 (see Fig.
2), became more pronounced as development advanced
beyond the heart looping stage. This progression was
particularly well resolved for the G6/lacZ-D1 line. Ex-
pression in the hearts of cG6/lacZ-D1 embryos sequen-
tially faded from the at (Fig. 4A), the future left ventricle
(Fig. 4B), and the future right ventricle (Figs. 4C and 4D)
and ultimately became confined to the outflow tract Fig.
4E). The two other cG6/lacZ-D lines displayed similar
(albeit more precocious) programs of downregulation in
the developing heart (Figs. 4F– 4G and 4H– 4I, respec-
tively).Copyright © 2000 by Academic Press. All rightEvidence for a Combinatorial Code between the
cGATA-6 Enhancer and the cGATA-6 Promoter
It is important to emphasize that the parental cG6/
lacZ-A construct was previously assayed at a single devel-
opment stage (i.e., E11) in transient transgenic mouse
embryos (He and Burch, 1997). In light of the transgenic
line-to-line variation in cGATA-6 enhancer-driven ventric-
ular expression that we now know exists at this develop-
mental stage (compare Figs. 4A, 4F, and 4H), the previously
reported ventricular (and outflow tract) expression for cG6/
lacZ-A embryos is hard to interpret. On the one hand, the
transgene might have been in the process of being down-
regulated in the two cG6/lacZ-A embryos examined. Alter-
natively, the combination of the cGATA-6 distal enhancer
and the cGATA-6 promoter might somehow have allowed
expression to persist in ventricular myocardium. To address
the latter possibility in a simplified context, we cloned the
1.4-kb (26.6 to 25.3 kb) cGATA-6 enhancer fragment in
front of the cGATA-6 promoter in the cG6/lacZ-B construct
and assayed the resultant construct (cG6/lacZ-C; see Fig. 1)
in two transgenic lines.
As expected, the cGATA-6 enhancer directs robust heart-
restricted expression between E7.5 and E9.5 in both cG6/
lacZ-C lines (data not shown). Likewise, as shown in Fig. 5,
robust expression persisted as late as E10.5 (Figs. 5A and 5B)
but faded soon thereafter (Figs. 5C and 5D). Indeed, the
expression patterns for cG6/lacZ-C embryos between E12.5
and E13.5 are similar in many ways to those seen for
cG6/lacZ-D embryos. For both constructs, expression de-
creased in the ventricles and became restricted to the
outflow tract (compare Figs. 4 and 5). On the other hand, the
combination of the cGATA-6 enhancer and promoter also
directs expression in the ventricular septum of the mul-
tichamber heart in both lines of cG6/lacZ-C mice (Figs. 5C
and 5D), a facet of expression not seen when the two control
regions were assayed separately (in cG6/lacZ-D and cG6/
lacZ-B, respectively; see Fig. 1). Expression in the ventric-
ular septum is clearly displayed in Fig. 5E, which shows a
section through the heart from Fig. 5D. This section, which
includes a weakly stained region of outflow tract myocar-
dium, also reveals expression in scattered myocardial cells
in the ventricular trabeculae. It is also obvious that expres-
sion in one of these lines persists in the atria at E13.5 (Fig.
5C) and even in neonates (data not shown).
The cGATA-6 Enhancer Contains Functionally
Relevant Nkx2.5 Binding Sites
In order to further delineate the cGATA-6 distal en-
hancer, we proceeded to assay two truncated derivatives of
the cG6/lacZ-D construct. As a first step, the right half (0.7
kb) of the distal (26.6 to 25.3 kb) fragment was deleted
from cG6/lacZ-D to yield cG6/lacZ-E (see Fig. 1). Transient
transgenic assays revealed that this deletion did not signifi-
cantly impair the activity of this enhancer (for example, see
Figs. 8A and 8B). We then proceeded to delete the left end
(0.2 kb) of the distal (26.6 to 26.0 kb) fragment from
cG6/lacZ-E to yield cG6/lacZ-F (see Fig. 1). This deletions of reproduction in any form reserved.
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315Nkx-Dependent cGATA-6 Enhancermarkedly reduced enhancer activity in all seven cG6/lacZ-F
transgenic embryos examined (for example, see Figs. 8E and
8F).
The sequence of the 643-bp (26.6 to 26.0 kb) cG6/lacZ-E
fragment, which displays robust enhancer activity, is
shown in Fig. 6. The cG6/lacZ-F (PstI) fragment, which
displays partial enhancer activity, comprises the more
proximal 456 bp of this sequence. The location of the
heart-specific HS site (at 26200) is also indicated.
A cursory examination of this sequence revealed poten-
FIG. 3. The cGATA-6 distal heart-specific enhancer is activated e
ssayed at E7.5 (A), E7.5–8 (B and C), E8.25 (D), E8.5 (E), and E9 (F
mbryo is shown in the inset in A, with arrows marking the loc
ransgene. Transverse sections of the embryos from B, C, and D a
onfirm that this transgene is expressed in cardiogenic mesode
ndocardium in the early looping heart (I).Copyright © 2000 by Academic Press. All rightial binding sites for several heart-restricted factors. High-
ighted in Fig. 6 are two such binding sites for Nkx2.5 (Chen
nd Schwartz, 1995), two for MEF-2C (Black and Olson,
998), four for GATA-4/5/6 (Ko and Engel, 1993; Merika
nd Orkin, 1993; Whyatt et al., 1993), and five (E boxes) for
HLH factors such as d/eHAND. Note that a GATA bind-
ng site and an E box map within the leftmost 0.2-kb region
hat is required for full enhancer activity.
One of the potential Nkx2.5 target sites in the cGATA-6
istal enhancer fragment contains a sequence (TGAAGTG)
in the cardiogenic program. Transgenic cG6/lacZ-D embryos were
enlarged image of the (boxed) cardiac crescent region of the E7.5
of individual cells within the cardiac crescent that express this
own in G, H, and I, respectively. The images shown in G and H
ells within the cardiac crescent. Expression is also evident inarly
). An
ation
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316 Davis, Wessels, and Burchthat is a perfect match to the Nkx2.5 consensus sequence
(TNAAGTG), as well as an overlapping sequence on the
other strand (TTcAGTG) that deviates from the consensus
FIG. 4. The cardiac-specific cGATA-6 enhancer is sequentially in
formation of the multichambered heart. Hearts from three lines of
and H), E11.5 (B), E12.5 (C, G, and I), E13.5 (D), and E14.5 (E). Not
tract in all three lines by E14.5. Abbreviations: atria (at), left ventrCopyright © 2000 by Academic Press. All rightt the third position (as indicated by the lowercase letter).
his site, denoted the Nkx2.5/A site, is located 6112 bp
pstream of the cGATA-6 gene (see Fig. 6). The other
ated along the posterior (venous) to anterior (arterial) axis during
lacZ-D mice were assayed in midgestational embryos at E11 (A, F,
t transgene expression becomes restricted to bands of the outflow
(lv), right ventricle (rv), outflow tract (ot).activ
cG6/
e tha
icles of reproduction in any form reserved.
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317Nkx-Dependent cGATA-6 Enhancerpotential Nkx2.5 binding site, denoted the Nkx2.5/B site,
lies 6394 bp upstream of the gene. This site deviates from
the consensus at one position (aGAAGTG) and thus was
predicted to have a lower affinity for Nkx2.5.
We carried out a gel shift assay to confirm that the
Nkx2.5/A and Nkx2.5/B sites are both bona fide Nkx2.5
binding sites. As shown in Fig. 7, a discrete gel shift
complex was obtained when each of the respective probes
was incubated with extracts from COS cells that had been
transfected with an Nkx2.5 expression vector (lanes 3 and
10), whereas no such complex was obtained with extracts
from control COS cells, which lack Nkx2.5 (lanes 2 and 9).
Note that the Nkx2.5/A site was revealed in this assay to
have a higher affinity for Nkx2.5 than the Nkx2.5/B site as
predicted (compare lanes 3 and 10). The Nkx2.5-dependent
gel shift complexes for both probes were competed by an
FIG. 5. Evidence for a combinatorial code between the cGATA-6
istal enhancer and the cGATA-6 promoter. Hearts from two lines
f cG6/lacZ-C transgenic mice (which contain the cGATA-6 distal
nhancer and the cGATA-6 promoter; see Fig. 1) were assayed at
10–10.5 and E12.5–13.5 (A–B and C–D, respectively). A cursory
nspection of the E12.5–13.5 hearts (C and D) reveals expression in
he ventricular septum (vs), which was not seen when the
GATA-6 enhancer and the cGATA-6 promoter were assayed
eparately (in cG6/lacZ-D and cG6/lacZ-B, respectively; see Fig. 1).
he ventricular septum is better visualized in the section shown in
, which was obtained from the heart shown in D. Note also that
ne of these cG6/lacZ-C lines also displays persistent atrial expres-
ion (C).Copyright © 2000 by Academic Press. All righty a previously characterized (Chen and Schwartz, 1995)
igh-affinity Nkx2.5 binding site (TCAAGTG; lanes 6 and
3). In contrast, these gel shift complexes were not com-
eted by a consensus MEF2 site (lanes 7 and 14) or by
utated Nkx2.5/A and Nkx2.5/B sites (lanes 5 and 12).
ote that the Nkx2.5/A mutation destroys both of the
otential Nkx2.5 sites within this sequence (see Materials
nd Methods).
To determine if these Nkx2.5 binding sites are important
or enhancer activity, the Nkx2.5/A and Nkx2.5/B sites
ere mutated in the context of the cG6/lacZ-E construct
which has robust enhancer activity) and the resultant
G6/lacZ-E-mut construct was evaluated in transient trans-
enic assays at E8.5–E9.5. The cGATA-6 enhancer was
ound to be severely crippled by this pair of Nkx2.5 binding
ite mutations. This was manifest, in part, by a reduced
raction of (PCR-positive) transgenic embryos that dis-
layed heart-restricted expression. In particular, whereas
FIG. 6. The cGATA-6 distal enhancer contains consensus binding
sites for several heart-restricted factors. Potential binding sites for
Nkx2.5, MEF-2C, GATA-4/5/6, and d/eHAND (E boxes) are
marked within the 643-bp enhancer fragment from the cG6/lacZ-E
construct (see Fig. 1). Note that most of these sites map between
the PstI sites (at 26406 and 25951) that delimit the 456-bp core
enhancer fragment from the cG6/lacZ-F construct (see Fig. 1). The
location of a distal heart-specific HS site (He and Burch, 1997) is
also indicated.s of reproduction in any form reserved.
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318 Davis, Wessels, and Burchheart-restricted expression was evident in 7/11 of the cG6/
lacZ-E transgenic embryos examined, mutations in the
Nkx2.5 binding sites reduced this “penetrance” to 2/12.
Moreover, the level of expression was severely reduced in
both of the embryos that did express this cG6/lacZ-E-mut
construct (see Figs. 8C and 8D).
DISCUSSION
The GATA-6 transcription factor is one of the earliest
markers of the cardiogenic lineage, being expressed in
committed precursor cells in the cardiac crescent in concert
with GATA-4/5, Nkx2.5, and TBX5 in diverse vertebrate
species (Jiang and Evans, 1996; Jiang et al., 1998; Kout-
ourakis et al., 1999; Morrisey et al., 1996). In the present
tudy we identified a chicken GATA-6 enhancer that func-
ions in transgenic mouse embryos and, moreover, is suffi-
FIG. 7. Nkx2.5 binds to two sites in the cGATA-6 distal en-
ancer. A gel shift assay was carried out using probes for the
kx2.5/A site (lanes 1–7) and the Nkx2.5/B site (lanes 8–14) from
he cGATA-6 distal enhancer (see Fig. 6). The core Nkx2.5 binding
ites within these probes are listed below the lane numbers. Note
hat the Nkx2.5/A probe has partially overlapping (perfect and
mperfect) consensus Nkx2.5 binding sites on opposite strands,
hereas the Nkx2.5/B probe contains a single (imperfect) binding
ite. These probes were assayed alone (lanes 1 and 8), with nuclear
xtracts from control COS cells (lanes 2 and 9), or with nuclear
xtracts from COS cells transfected with an Nkx2.5 expression
ector (lanes 3–7 and 10–14). Competition assays were carried out
ith an excess of the respective unlabeled sites (lanes 4 and 11),
utated versions of these sites (lanes 5 and 12), a bona fide
igh-affinity Nkx2.5 binding site (lanes 6 and 13), and a heterolo-
ous (MEF-2) site (lanes 7 and 14), as indicated.Copyright © 2000 by Academic Press. All rightardiogenic lineage, namely, from the cardiac crescent stage
hrough the linear heart stage. As development proceeds
eyond the early heart-looping stage, however, this en-
ancer becomes downregulated in atrial and ventricular
yocardium and displays a bias for outflow tract myocar-
ium. Remarkably, these dynamic features of cGATA-6
nhancer activity reflect, in broad outline, previously re-
orted dynamic features of endogenous cGATA-6 expres-
ion (Jiang et al., 1998; Laverriere et al., 1994). (Note that
he endogenous mGATA-6 gene appears to be expressed
ore uniformly over the course of heart morphogenesis
Morrisey et al., 1997).) The endogenous cGATA-6 gene is
ownregulated less severely than the cGATA-6 transgene,
owever, and continues to be expressed at moderate levels
n the adult heart (Laverriere et al., 1994). We therefore infer
hat the endogenous cGATA-6 gene must be flanked by
dditional heart-specific enhancers. Indeed, we have iden-
ified one such heart-region-specific enhancer which func-
ions in myocardial cells that reside within the atrioven-
ricular canal (He and Burch, 1997).
The sequence of the cGATA-6 enhancer contains poten-
ial binding sites for several classes of heart-restricted
actors and we determined that at least one of the Nkx2.5
inding sites is critical for enhancer activity. Interestingly,
he mGATA-6 gene has similarly been shown to be regu-
ated by an Nkx-dependent enhancer (Molkentin et al.,
000). Conversely, two of the enhancers that flank the
Nkx2.5 gene were recently shown (in analogous trans-
enic mouse assays) to be regulated by the GATA-4/5/6
lass of factors during early stages of heart development
Lien et al., 1999; Searcy et al., 1998). To our knowledge,
hese are the only reported examples of direct feedback
oops between heart-restricted transcription factor genes.
hese feedback loops presumably serve to internally rein-
orce the externally derived endodermal signals that com-
it precursor cells to the cardiogenic program.
The presence of bona fide binding sites for Nkx2.5, as
ell as potential binding sites for GATA-4/5/6, MEF-2C,
/eHAND, and various ubiquitous factors, would appear to
eatly account for the activity of the cGATA-6 distal
nhancer in committed cardiogenic cells that reside within
he cardiac crescent and subsequently give rise to the
rimitive heart. The close proximity of Nkx2.5 and GATA-
/5/6 sites within the cGATA-6 distal enhancer is particu-
arly noteworthy, as similar pairs of sites have been shown
o function as powerful cardiac-specific regulatory modules
n other enhancers and promoters (Durocher et al., 1997;
ee et al., 1998; Sepulveda et al., 1998). By the same token,
ne might have predicted that this myriad of binding sites
or early and persistent heart-restricted factors would be
ufficient to allow this enhancer to remain active during
ater stages of heart development. Instead, this enhancer is
equentially downregulated along the posterior to anterior
xis of the looping heart at a time when many endogenous
eart-specific genes switch from general to heart-region-
pecific expression patterns (reviewed in Kelly et al., 1999).s of reproduction in any form reserved.
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319Nkx-Dependent cGATA-6 EnhancerThe schedules of cGATA-6 enhancer downregulation vary
somewhat between different lines that harbor the same
cG6/lacZ construct. We infer that differences in transgene
copy number or integration site render the cGATA-6 distal
enhancer more or less sensitive to factors that effect the
downregulation of the cGATA-6 transgene and that pre-
sumably orchestrate the reprogramming of many endoge-
nous cardiac genes.
Having determined that Nkx2.5 binding sites are impor-
tant for cGATA-6 enhancer activity during early stages of
development, it is obvious to consider whether the inacti-
vation of this enhancer might reflect a decrease in the
FIG. 8. Mutations in the Nkx2.5 binding sites cripple the cGATA
ufficient to direct robust heart-specific transgene expression at E8
). Deleting 187 bp from the left end of this 643-bp fragment attenu
f the cG6/lacZ-F transgene (see Fig. 1) at E8.5 (E) and E9.5 (F). Th
kx2.5 binding sites were mutated, as evidenced by the results shCopyright © 2000 by Academic Press. All rightccupancy of these binding sites during later stages of heart
evelopment. Although there is no evidence to suggest that
kx2.5 activity decreases as development proceeds beyond
he heart-looping stage, the fact that Nkx2.5 belongs to a
ultigene family raises the possibility that the activity of
his cGATA-6 enhancer may require binding by another
amily member that is differentially expressed early in the
ardiogenic lineage. It therefore may be relevant to note
hat cNkx2.8 is downregulated after the heart-looping stage
n chick embryos (Reecy et al., 1997). However, a mouse
omolog of this factor has not yet been reported.
Although MEF-2 activity has been reported to decrease in
tal enhancer. The 643-bp distal enhancer fragment (see Fig. 6) was
) and E9.5 (B) in the context of the cG6/lacZ-E construct (see Fig.
enhancer activity, as evidenced by the relatively weak expression
-bp enhancer fragment was more severely crippled when the two
in C and D for the cG6/lacZ-E-mut construct.-6 dis
.5 (A
ated
e 643
owns of reproduction in any form reserved.
the developing heart (Naya et al., 1999), this appears to
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program for outflow tract myocardium remains to be elu-
320 Davis, Wessels, and Burchccur too late (i.e., after E14.5) to account for the observed
ecrease in cGATA-6 enhancer activity. On the other hand,
he sequence or context of the presumptive MEF-2 sites
ay render the cGATA-6 enhancer more sensitive to a
ubtle decrease in MEF-2 activity than the tandem repeat of
hree MEF-2 sites used in the other study. Indeed, the latter
EF-2 construct is itself more sensitive to decreased MEF-2
ctivity than a transgene driven by the single MEF-2 site in
he minimal MLC-2v enhancer (Ross et al., 1996).
The cGATA-6 distal enhancer also contains five E boxes
hich are potential binding sites for d/eHAND (or other
HLH) factors. Interestingly, d/eHAND are expressed uni-
ormly in the cardiac crescent at E7.5 but become restricted
o distinct regions of the primitive heart (Srivastava et al.,
997). The dynamic pattern of dHAND expression is actu-
lly quite similar to that of cG6/lacZ-D. Additional experi-
ents will be required to test if this correlation is function-
lly significant.
Alternatively, it is possible that a negative factor func-
ions in a dominant manner to downregulate the cGATA-6
istal enhancer as development proceeds beyond the early
eart-looping stage. Ironically, the heart-specific HS site
hat originally led us to identify this enhancer might
ctually mark the site of a bound repressor since mature
earts were used for our original HS site analysis (He and
urch, 1997). In considering factors that might function as
epressors in this context, it may be relevant to note that
he cGATA-6 distal HS site maps in the immediate vicinity
f a VDR half site (AGGACA at position 26209; see Fig, 6)
kin to the VDR-like element that negatively regulates the
low MyHC 3 gene after the heart-looping stage (Wang et
l., 1998). Although the slow MyHC 3 gene is repressed in
entricular (but not atrial) myocardium, gel shift assays
ith the VDR-like element revealed similar binding activi-
ies in ventricular and atrial extracts. This suggests that the
equence or context of the VDR-like element may dictate
hether this module functions as a negative control ele-
ent in one or more chambers of the heart. Negative
egulatory modules have also been identified upstream of
he Nkx2.5 gene but these have not been characterized in
ny detail (Lien et al., 1999; Reecy et al., 1999; Tanaka et
l., 1999b).
The cGATA6 distal enhancer displays persistent activity
n the outflow tract, an interesting region of the heart that
ppears to serve different functions over the course of
ardiac development (Moorman and Lamers, 1994). Prior to
he formation of valves, the outflow tract is a relatively long
egment with novel functional properties that prevent the
everse flow of blood during relaxation of the primitive
entricle (Moorman and Lamers, 1994, 1995). Subse-
uently, the outflow tract myocardium appears to serve
rimarily as a supportive sphincter around the developing
emilunar valves (Wessels et al., 1990, 1991). After valves
ave been formed, the remnants of the myocardial outflow
ract become incorporated into the outlet segment of the
ight ventricle (Franco et al., 1997). Although the geneticCopyright © 2000 by Academic Press. All rightcidated, the existence of a distinct transcriptional milieu in
these cells is clearly indicated by the segmental expression
patterns of endogenous genes such as dHAND (Srivastava et
al., 1995) and min-K (Kupershmidt et al., 1999) and trans-
genes driven by enhancers for cGATA-6 (this report),
mNkx2.5 (Searcy et al., 1998), and MLC3F (Franco et al.,
1997) genes.
In conclusion, we have identified a functionally con-
served enhancer that is sufficient to account for the early
heart-restricted expression of the cGATA-6 gene. This
643-bp distal enhancer also provides a model to further
analyze the downregulation of an early heart-restricted
program and the shift to heart-region-specific programs as
the heart matures from a simple tube into a multicham-
bered organ.
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